信达生物2024业绩公告:年内亏损9463万元,同比减90.8%

财中社
26 Mar

3月26日,信达生物(01801)发布截至2024年12月31日止年度业绩公告。公司实现收入94.22亿元,同比增长51.8%。毛利达到79.12亿元,增幅为56.1%。年内亏损显著收窄至9463万元,较去年同期的10.28亿元减少90.8%。此外,首次实现Non-IFRS利润转正,达到3.32亿元,反映出公司经营效率的持续改善和收入的强劲增长。财务回顾显示,收入增长主要归因于产品销售的显著提升,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."